首页|医院集中带量采购品种可替代药品监测和精细化管理探索

医院集中带量采购品种可替代药品监测和精细化管理探索

扫码查看
目的 提升医院集中带量采购(简称集采)品种可替代药品的监测和精细化管理水平。方法 根据国家、省际联盟药品集采相关政策,结合目前医院药品集采工作执行情况,按照药品的解剖学、治疗学及化学分类系统,药品说明书,指南等,采用Power BI软件,在前期集采药品智能监控系统基础上扩展可替代药品监测和管理相关功能模块。结果 扩展新增了可替代药品监测和管理模块及重点科室使用监测功能模块,进一步实现了可替代药品监控、集采中选药品缺药时的可替代药品管理、医疗机构基本用药目录优化、重点科室使用监测等功能。结论 功能扩展后的集采药品智能监控系统,可促进集采药品管理工作的精细化、智能化,为医疗机构建立完善的集采药品全流程科学管理提供技术支持。
Exploration of Monitoring and Refined Management of Alternative Medicines for Centralized-Procurement Varieties in the Hospital
Objective To promote the monitoring and refined management of alternative medicines for centralized-procurement varieties in hospitals.Methods According to the relevant policies of national and inter-provincial alliance drug procurement,the current implementation of drug procurement in the hospital,anatomical therapeutic chemical,drug instructions,guidelines,etc.,the Power BI software was used to develop the monitoring and management-related functional modules of alternative medicines on the basis of the early centralized-procurement drug intelligent monitoring system.Results The functional modules including monitoring and management of alternative medicines and use monitoring of these medicines in key departments had been added,which helped to monitor the alternative medicines,manage the alternative medicines in case of shortage of centralized-procurement drugs,optimize the basic drug catalogue of medical institutions,and monitor the use of alternative medicines in key departments.Conclusion The centralized-procurement drug intelligent monitoring system with new functions can promote the refinement and intelligence of centralized-procurement drug management,and provide technical supports for medical institutions to establish a perfect entire-process scientific management system for the centralized-procurement drugs.

centralized drug procurementalternative medicineintelligent monitoringpharmacy management

李雅琴、刘华、王芳、薛维佳、赵宁一、蒙婷、李里

展开 >

四川大学华西医院,四川 成都 610041

药品集中带量采购 可替代药品 智能监测 药房管理

四川省财政厅会计科研项目

2022-sckjkt-007

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(20)